TY - JOUR AU - Ferreri, A. J. AU - Abrey, L. E. AU - Blay, J. Y. AU - Borisch, B. AU - Hochman, J. AU - Neuwelt, E. A. PY - 2003 DA - 2003// TI - Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002 JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.01.135 DO - 10.1200/JCO.2003.01.135 ID - Ferreri2003 ER - TY - JOUR AU - Bataille, B. AU - Delwail, V. AU - Menet, E. AU - Vandermarcq, P. AU - Ingrand, P. AU - Wager, M. PY - 2000 DA - 2000// TI - Primary intracerebral malignant lymphoma: report of 248 cases JO - J Neurosurg VL - 92 UR - https://doi.org/10.3171/jns.2000.92.2.0261 DO - 10.3171/jns.2000.92.2.0261 ID - Bataille2000 ER - TY - JOUR AU - Ferreri, A. J. AU - Reni, M. AU - Foppoli, M. AU - Martelli, M. AU - Pangalis, G. A. AU - Frezzato, M. PY - 2009 DA - 2009// TI - High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61416-1 DO - 10.1016/S0140-6736(09)61416-1 ID - Ferreri2009 ER - TY - JOUR AU - Ferreri, A. J. AU - Dell'Oro, S. AU - Foppoli, M. AU - Bernardi, M. AU - Brandes, A. A. AU - Tosoni, A. PY - 2006 DA - 2006// TI - MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas JO - Neurol VL - 66 UR - https://doi.org/10.1212/01.wnl.0000210464.94122.e1 DO - 10.1212/01.wnl.0000210464.94122.e1 ID - Ferreri2006 ER - TY - JOUR AU - Illerhaus, G. AU - Marks, R. AU - Ihorst, G. AU - Guttenberger, R. AU - Ostertag, C. AU - Derigs, G. PY - 2006 DA - 2006// TI - High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.2117 DO - 10.1200/JCO.2006.06.2117 ID - Illerhaus2006 ER - TY - JOUR AU - Illerhaus, G. AU - Muller, F. AU - Feuerhake, F. AU - Schafer, A. O. AU - Ostertag, C. AU - Finke, J. PY - 2008 DA - 2008// TI - High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system JO - Haematologica VL - 93 UR - https://doi.org/10.3324/haematol.11771 DO - 10.3324/haematol.11771 ID - Illerhaus2008 ER - TY - JOUR AU - Pfreundschuh, M. AU - Kuhnt, E. AU - Trumper, L. AU - Osterborg, A. AU - Trneny, M. AU - Shepherd, L. PY - 2011 DA - 2011// TI - CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70235-2 DO - 10.1016/S1470-2045(11)70235-2 ID - Pfreundschuh2011 ER - TY - STD TI - Ferreri AJ, Cwynarski K, Pulczynski E, et al, for the International Extranodal Study Group (IELSG). Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016; published online April 6. ID - ref8 ER - TY - JOUR AU - Rubenstein, J. L. AU - Hsi, E. D. AU - Johnson, J. L. AU - Jung, S. H. AU - Nakashima, M. O. AU - Grant, B. PY - 2013 DA - 2013// TI - Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202) JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.9957 DO - 10.1200/JCO.2012.46.9957 ID - Rubenstein2013 ER - TY - JOUR AU - Motomura, K. AU - Natsume, A. AU - Fujii, M. AU - Ito, M. AU - Momota, H. AU - Wakabayashi, T. PY - 2011 DA - 2011// TI - Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy JO - Leuk Lymphoma VL - 52 UR - https://doi.org/10.3109/10428194.2011.596967 DO - 10.3109/10428194.2011.596967 ID - Motomura2011 ER - TY - JOUR AU - Ponzoni, M. AU - Issa, S. AU - Batchelor, T. T. AU - Rubenstein, J. L. PY - 2014 DA - 2014// TI - Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt385 DO - 10.1093/annonc/mdt385 ID - Ponzoni2014 ER - TY - JOUR AU - Rubenstein, J. L. AU - Gupta, N. K. AU - Mannis, G. N. AU - Lamarre, A. K. AU - Treseler, P. PY - 2013 DA - 2013// TI - How I treat CNS lymphomas JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-06-453084 DO - 10.1182/blood-2013-06-453084 ID - Rubenstein2013 ER - TY - JOUR AU - Illerhaus, G. AU - Fritsch, K. AU - Egerer, G. AU - Lamprecht, M. AU - Bubnoff, N. AU - Wolf, H. H. PY - 2012 DA - 2012// TI - Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg JO - Blood VL - 120 ID - Illerhaus2012 ER - TY - JOUR AU - Soussain, C. AU - Hoang-Xuan, K. AU - Taillandier, L. AU - Fourme, E. AU - Choquet, S. AU - Witz, F. PY - 2008 DA - 2008// TI - Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Societe Francaise de Greffe de Moelle Osseuse-Therapie Cellulaire JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.5533 DO - 10.1200/JCO.2007.13.5533 ID - Soussain2008 ER - TY - JOUR AU - Kasenda, B. AU - Schorb, E. AU - Fritsch, K. AU - Finke, J. AU - Illerhaus, G. PY - 2012 DA - 2012// TI - Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds059 DO - 10.1093/annonc/mds059 ID - Kasenda2012 ER - TY - JOUR AU - Soussain, C. AU - Suzan, F. AU - Hoang-Xuan, K. AU - Cassoux, N. AU - Levy, V. AU - Azar, N. PY - 2001 DA - 2001// TI - Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma JO - J Clin Oncol VL - 19 ID - Soussain2001 ER - TY - JOUR AU - Abrey, L. E. AU - Batchelor, T. T. AU - Ferreri, A. J. AU - Gospodarowicz, M. AU - Pulczynski, E. J. AU - Zucca, E. PY - 2005 DA - 2005// TI - Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.13.524 DO - 10.1200/JCO.2005.13.524 ID - Abrey2005 ER - TY - JOUR AU - Ferreri, A. J. AU - Blay, J. Y. AU - Reni, M. AU - Pasini, F. AU - Spina, M. AU - Ambrosetti, A. PY - 2003 DA - 2003// TI - Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.09.139 DO - 10.1200/JCO.2003.09.139 ID - Ferreri2003 ER -